Experimental findings from the present study show that HDAC3 inhibition may protect against T2DM-induced BBB permeability, and the beneficial effect is at least in part attributed by miR-200a/Keap1/Nrf2 pathway. The gene discussed is KEAP1; the disease is type 2 diabetes mellitus.